通过前向和逆向翻译来识别乳腺癌亚型和预测药物反应
Julie Karam1, Paul A Rejto1, Jadwiga Renata Bienkowska1
1Pfizer Oncology Research and Development La Jolla, San Diego, CA, USA.
NPJ precision oncology
|July 31, 2025
概括
研究人员使用基因表达数据确定了不同的乳腺癌亚型. 这些亚型揭示了特定的脆弱性,预测了针对性治疗的有效性,如对某些乳腺癌 (BRCA) 患者的CDK6抑制.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 乳腺癌 (BRCA) 是全球癌症死亡的主要原因.
- 生物标志物对于预测治疗反应和改善患者结果至关重要.
研究的目的:
- 使用基因表达数据识别新的乳腺癌亚型.
- 描述这些亚型并预测亚型特定的治疗脆弱性.
主要方法:
- 应用大量基因表达解卷和贝叶斯NMF与共识等级集群到TCGA BRCA样本.
- 进行综合性基因组分析以表征亚型并确定治疗点.
- 利用瘤组织和细胞系之间的反向和前向翻译.
主要成果:
- 确定了七种批量表达亚型 (B1-B7) 和五种特定于癌细胞的亚型 (C1-C5).
- 癌细胞特异性亚型5 (C5) 显示出对CDK6和TPI1抑制的预测脆弱性.
- 分型C4和C5分别表现出CDK4和CDK6的依赖性.
结论:
- 贝叶斯NMF聚类确定了强大的BRCA表达亚型.
- 瘤组织和细胞系之间的转化分析成功预测了亚型特定的脆弱性.
- 这种方法有助于指导个性化乳腺癌治疗策略.
更多相关视频
11:12Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.1K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K